Overview
Ozempic Pen 0.25 mg contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used in managing type 2 diabetes mellitus. This dose is typically used as the initial starting dose to help patients gradually adapt to the medication, minimizing side effects while beginning to improve blood sugar control. It is administered as a once-weekly subcutaneous injection.





